期刊文献+

类风湿关节炎患者血清IL-35的水平及其与疾病活动度的关系 被引量:15

The levels of serum interleukin 35 in patients with rheumatoid arthritis and its correlation with disease activity
下载PDF
导出
摘要 目的探讨类风湿关节炎(RA)患者血清IL-35表达水平与疾病活动度的相关性。方法选取确诊RA患者118例,分为活动期组62例和缓解期组56例。同时选取90例健康人作为对照,ELISA法检测RA患者及对照者血清IL-35水平,实时荧光定量PCR检测外周血单个核细胞(PBMC)中IL-35亚基EBI3和P35 mRNA表达水平。分析血清IL-35水平与DAS28评分、C反应蛋白(CRP)、红细胞沉降率(ESR)、类风湿因子(RF)、关节肿胀数(SJC)和关节压痛数(TJC)等的相关性。结果活动期组RA患者血清中IL-35浓度(38.09±16.90)pg/m L显著低于对照组[(82.25±15.82)pg/m L,P<0.01)]和缓解期组[(72.96±11.74)pg/m L,P<0.01)];依据DAS28评分将活动期组RA患者分为轻度、中度和重度组,血清IL-35水平(pg/m L)在3组中依次降低(轻度60.95±7.31,中度39.68±9.51,重度28.02±9.16),轻度组与中度或重度组间差异具有统计学意义(P<0.05)。活动期组和缓解期组患者血清IL-35水平与SJC、CRP和DAS28评分呈负相关性(P<0.05),与ESR、TJC、RF无相关性。PBMC中P35 mRNA在RA活动期组中显著降低,低于健康对照组和缓解期组(0.47±0.18 vs 1.91±1.12&1.82±0.53,P<0.01),但EBI3 mRNA在活动期组(1.62±0.68)、缓解期组(1.48±0.77)及对照组(1.86±1.21)中差异无统计学意义(P>0.05)。结论活动期组RA患者血清IL-35水平显著下降,且伴随P35 mRNA水平下降,并与RA疾病活动度密切相关,可作为RA疾病活动度评价的潜在指标。 Objective To investigate the correlation of serum interleukin 35( IL-35) levels with disease activity in the patients with rheumatoid arthritis( RA). Methods 118 patients with RA,including 62 in active stage and 56 in remission stage,and 90 healthy controls were enrolled in our study. The levels of serum IL-35 were detected by ELISA,and the mRNA expression levels of subunits epstein-barr virus induced 3( EBI3) and P35 of IL-35 in peripheral blood mononuclear cells( PBMC) were determined by real-time quantitative PCR. The correlations of serum IL-35 levels with clinical parameters such as DAS28 score,C-reactive protein( CRP),erythrocyte sedimentation rate( ESR),rheumatoid factor( RF),swollen joint count( SJC) and tender joint count( TJC) were analyzed. Results The levels of serum IL-35 in patients with active RA [( 38. 09 ± 16. 90) pg / m L] were significantly lower than those in remission RA patients [( 72. 96 ± 11. 74) pg / m L] and healthy controls [( 82. 25 ± 15. 82) pg / m L]( P〈0. 01). When the active RA patients were divided into mild,moderate and severe RA based on DAS28 score,their serum IL-35 levels reduced in turn at this sequence( 60. 95 ± 7. 31) pg / m L,( 39. 68 ± 9. 51) pg / m L and( 28. 02 ± 9. 16) pg / m L,and the former significantly higher than the later two( P〈0. 05). The serum IL-35 levels in active and remission RA patients were negatively correlated with SJC,CRP levels and DAS28 score( P〈0. 05),but not related to ESR,TJC and RF levels. The p35 mRNA levels in PBMC of active RA patients( 0. 47 ±0. 18) were significantly lower than those in remission RA patients( 1. 82 ± 0. 53) and healthy controls( 1. 91 ± 1. 12)( P〈0. 01),while there was no significant difference in mRNA levels of EBI3 among the three groups( 1. 62 ± 0. 68,1. 48 ± 0. 77 and 1. 86 ±1. 21,P〉0. 05). Conclusion The serum IL-35 and the related p35 mRNA levels decreased significantly in active RA patients,and were closely correlated with disease activity,indicating that IL-35 may be a potential marker for evaluating the activity of RA.
出处 《临床检验杂志》 CAS CSCD 2016年第4期277-280,共4页 Chinese Journal of Clinical Laboratory Science
关键词 类风湿关节炎 IL-35 DAS28 EBI3 P35 rheumatoid arthritis interleukin 35 DAS28 score epstein-barr virus induced 3 P35
  • 相关文献

参考文献13

  • 1Boissier MC. Cell and cytokine imbalances in rheumatoid synovitis [J]. Joint Bone Spine, 2011, 78(3) : 230-234.
  • 2Miyara M, Ito Y, Sakaguchi S. TREG-cell therapies for autoimmune rheumatic diseases[ J]. Nat Rev Rheumatol, 2014, 10 (9) : 543- 551.
  • 3Choi J, Leung PS, Bowlus C, et al. IL-35 and Autoimmunity: a Comprehensive Perspective [ J ]. Clin Rev Allergy Immunol, 2015, 49(3) : 327-332.
  • 4Olson BM, Sullivan JA, Burlingham WJ. Interleukin 35 : a key me- diator of suppression and the propagation of infectious tolerance [ J ]. Front Immunol, 2013, 4(4) : 315-315.
  • 5Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the ex- pansion of regulatory T cells and suppression of TH17 cells[ J]. Eur J Immunol, 2007, 37( 11): 3021-3029.
  • 6Thiolat A, Denys A, Petit M, et al. Interleukin-35 gene therapy ex- acerbates experimental rheumatoid arthritis in mice [ J ]. Cytokine, 2014, 69(1) : 87-93.
  • 7类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1320
  • 8Hamidinia M, Ghafourian BM, Talaiezadeh A, et al. Increased P- 35, EBI3 transcripts and other Treg markers in peripheral blood mononuclear cells of breast cancer patients with different clinical sta- ges[J]. Adv Pharm Bull, 2015, 5(2) : 261-267.
  • 9Mclnnes IB, Schett G. The pathogenesis of rheumatoid arthritis[J]. NEJM, 2011,365(23) : 2205-2219.
  • 10McInnes I B, Schett G. Cytokines in the pathogeuesis of rheumatoid arthritis [ J ]. Nat Rev Immunol, 2007, 7 (6) : 429-442.

共引文献1319

同被引文献94

引证文献15

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部